Cellosaurus HK-CRISPR-mEGFP-CAP-H2 no.1 (CVCL_UR46)
| Cell line name | HK-CRISPR-mEGFP-CAP-H2 no.1 |
|---|---|
| Synonyms | HK CRISPR mEGFP-CAP-H2; HK CRISPR mEGFP-NCAPH2 #1 |
| Accession | CVCL_UR46 |
| Resource Identification Initiative | To cite this cell line use: HK-CRISPR-mEGFP-CAP-H2 no.1 (RRID:CVCL_UR46) |
| Comments | Population: African American. Characteristics: Using CRISPR/Cas9D10A NCAPH2 (CAP-H2) has been endogenously tagged in both alleles at the N-terminus with mEGFP. Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP). Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. |
| Disease | Human papillomavirus-related endocervical adenocarcinoma (NCIt: C27677) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_1922 (HeLa Kyoto) |
| Sex of cell | Female |
| Age at sampling | 30Y6M |
| Category | Cancer cell line |
| Publications | PubMed=29632028; DOI=10.1083/jcb.201801048; PMCID=PMC6028534 PubMed=30202089; DOI=10.1038/s41586-018-0518-z; PMCID=PMC6556381 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q94210587 |
| Entry history | |
| Entry creation | 25-Feb-2019 |
| Last entry update | 10-Apr-2025 |
| Version number | 8 |